131 related articles for article (PubMed ID: 11379319)
1. Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results.
Bektas A; Yasa MH; Kuzu I; Dogan I; Unal S; Ormeci N
Hepatogastroenterology; 2001; 48(38):408-12. PubMed ID: 11379319
[TBL] [Abstract][Full Text] [Related]
2. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus.
Safatle-Ribeiro AV; Ribeiro U; Sakai P; Clarke MR; Fylyk SN; Ishioka S; Gama-Rodrigues J; Finkelstein SD; Reynolds JC
Cancer Detect Prev; 2000; 24(1):13-23. PubMed ID: 10757119
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
7. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer].
Naitoh H; Kawaguchi A; Shibata J; Umeda T; Kodama M; Hattori T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():110-4. PubMed ID: 7611771
[TBL] [Abstract][Full Text] [Related]
11. Lugol staining and histological evaluation of esophageal mucosa in achalasia.
Yamamuro EM; Cecconello I; Iriya K; El Ibrahim R; Rodrigues JG; Pinotti HW
Hepatogastroenterology; 2006; 53(70):506-10. PubMed ID: 16995450
[TBL] [Abstract][Full Text] [Related]
12. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
13. Image cytometric DNA analysis of mucosal biopsies in patients with primary achalasia.
Gockel I; Kammerer P; Brieger J; Heinrich UR; Mann WJ; Bittinger F; Eckardt VF; Junginger T
World J Gastroenterol; 2006 May; 12(19):3020-5. PubMed ID: 16718781
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
16. [Association of p53, PCNA expression and trace element content in esophageal mucosa].
Zhao WX; Shi TX; Gao XP; Zhang HX; Li SL
Ai Zheng; 2002 Jul; 21(7):757-60. PubMed ID: 12479101
[TBL] [Abstract][Full Text] [Related]
17. p53 and MIB-1 expression of esophageal carcinoma concominant with achalasia.
Iwata T; Kurita N; Nishioka M; Miyamoto H; Wakatsuki S; Sano T; Tashiro S; Shimada M
Hepatogastroenterology; 2007; 54(77):1430-2. PubMed ID: 17708270
[TBL] [Abstract][Full Text] [Related]
18. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
19. DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions.
Yasa MH; Bektas A; Yukselen V; Akbulut H; Camci C; Ormeci N
Int J Clin Pract; 2005 Sep; 59(9):1029-33. PubMed ID: 16115177
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
